Related Experiment Video
Updated: Aug 9, 2026
08:20
A Reliable and Reproducible Critical-Sized Segmental Femoral Defect Model in Rats Stabilized with a Custom External Fixator
Published on: March 24, 2019
Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats
Masaki Endo1, Shinji Kuroda, Hisatomo Kondo
1Oral Implantology and Regenerative Dental Medicine, Tokyo Medical and Dental University, Tokyo, Japan. memfc@tmd.ac.jp
Tissue Engineering
|April 4, 2006
Summary
Modified gene-activated matrix (GAM) with calcium-phosphate (CaP) significantly enhances bone regeneration. This CaP-modified GAM effectively bridges bone defects, offering a promising approach for tissue regeneration with lower DNA doses.
Area of Science:
- Biomaterials Science
- Tissue Engineering
- Regenerative Medicine
Background:
- Gene-activated matrix (GAM) systems utilize matrices encoding regenerative proteins.
- Original GAM systems suffered from low gene transfer efficiency.
- Modification of GAM with calcium-phosphate precipitates (CaP) was shown to enhance gene transfer.
Purpose of the Study:
- To evaluate the efficacy of CaP-modified GAM in promoting tissue regeneration.
- To assess the impact of CaP on gene transfer efficiency within the GAM system.
- To determine the optimal conditions for bone defect repair using modified GAM.
Main Methods:
- Preparation of critical size segmental bone defects in rat tibiae.
- Transplantation of GAM composed of atelocollagen and BMP2 expression plasmid, with or without CaP.
- Radiographic, histological, and mechanical analysis of bone regeneration.
Main Results:
- BMP2-CaP-collagen successfully bridged bone defects within 4 weeks, achieving intact tibia strength by 6 weeks.
- BMP2-collagen alone showed less effective bone bridging at the same BMP2 dose.
- Neither collagen alone nor vacant vector-CaP-collagen facilitated bone defect bridging.
Conclusions:
- CaP modification significantly enhances the efficacy of GAM for bone regeneration.
- The modified GAM system demonstrates potential for effective tissue regeneration at reduced plasmid DNA doses.
- This approach offers a promising strategy for accelerating bone defect healing.
